This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

eTheRNA

Profile

eTheRNA manufacturing builds on more than 30 years of manufacturing research grade mRNA, and more than 5 years of GMP mRNA production. Following our foundation at the labs of the VUB in Brussels, since 2018 all RNA production is performed in our GMP approved facility in Niel, Belgium. As an experienced RNA CDMO we now offer our expertise and capabilities as a one stop service to bring your RNA-based research and products from the lab to the clinic. We also offer a bespoke LNP formulation development and production service, tailored to deliver your drug substance to your target organ or tissue with superior preclinical efficacy compared to currently available formulations. Our service is designed to support discovery and early pre-clinical development projects and provides you access to proprietary lipids, innovative and differentiated formulations, targeted delivery and tailored biodistribution.